Literature DB >> 29184969

Out-of-pocket health expenditures in patients with bipolar disorder, anxiety, schizophrenia and other psychotic disorders: findings from a study in a psychiatry outpatient clinic in Turkey.

Duygu Islek1, Bulent Kilic2, Berna Binnur Akdede3.   

Abstract

PURPOSE: The aim of this study is to explore the amount of OOP health expenditures and their determinants in patients with bipolar disorder, anxiety, schizophrenia and other psychotic disorders in a psychiatry outpatient clinic of Turkey.
METHODS: The study group was 191 patients who attended to the Psychiatry Outpatient Clinic in June 2014. All patients were previously diagnosed with either 'bipolar disorder', 'anxiety disorder' or 'schizophrenia and other psychotic disorders'. The dependent variable was OOP expenditures for prescription, medical tests and examinations. Independent variables were age, gender, education, occupation, existence of social and/or private health insurance, equivalent household income and the financial resources. Student's t test, Mann-Whitney U test, ANOVA and logistic regression methods were applied with SPSS 15.0 for analysis.
RESULTS: OOP expenditures per admission were higher in patients with schizophrenia and other psychotic disorders ($8.4) than those with anxiety disorders ($4.8) (p = 0.02). OOP expenditures were higher in patients paying with debit ($9.8) than paying with monthly income ($6.2) (p = 0.04). OOP expenditures were higher in patients without social health insurance ($45.8) than others ($4.8) (p = 0.003). There was not a difference in OOP expenditures with respect to equivalent household income level, occupational class or education level of the patients (respectively p: 0.90, p: 0.09, p: 0.52).
CONCLUSIONS: Patients who were diagnosed with 'schizophrenia and other psychotic disorders' were disadvantaged in paying significantly higher amounts for their treatment. A substantial group of these patients compulsorily payed with debit. Considering this financial burden, diagnosis of the patient should be prioritized in health insurance coverage.

Entities:  

Keywords:  Anxiety disorder; Bipolar disorder; Out-of-pocket health expenditures; Schizophrenia and other psychotic disorder; Social determinants; Social insurance

Mesh:

Year:  2017        PMID: 29184969     DOI: 10.1007/s00127-017-1465-y

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  16 in total

1.  Budget and financing of mental health services: baseline information on 89 countries from WHO's project atlas.

Authors:  Shekhar Saxena; Pratap Sharan; Benedetto Saraceno
Journal:  J Ment Health Policy Econ       Date:  2003-09

2.  Differences in medical care expenditures for adults with depression compared to adults with major chronic conditions.

Authors:  Ithai Z Lurie; Larry M Manheim; Dorothy D Dunlop
Journal:  J Ment Health Policy Econ       Date:  2009-06

3.  Material standard of living, social class, and the prevalence of the common mental disorders in Great Britain.

Authors:  S Weich; G Lewis
Journal:  J Epidemiol Community Health       Date:  1998-01       Impact factor: 3.710

4.  Relationship between household income and mental disorders: findings from a population-based longitudinal study.

Authors:  Jitender Sareen; Tracie O Afifi; Katherine A McMillan; Gordon J G Asmundson
Journal:  Arch Gen Psychiatry       Date:  2011-04

5.  Out-of-Pocket expenditure for depression among patients attending private community psychiatric clinics in Pakistan.

Authors:  Amin A Gadit
Journal:  J Ment Health Policy Econ       Date:  2004-03

Review 6.  Poverty and common mental disorders in developing countries.

Authors:  Vikram Patel; Arthur Kleinman
Journal:  Bull World Health Organ       Date:  2003-10-14       Impact factor: 9.408

7.  Trends in mental health insurance benefits and out-of-pocket spending.

Authors:  David R McKusick; Tami L Mark; Edward C King; Rosanna M Coffey; James Genuardi
Journal:  J Ment Health Policy Econ       Date:  2002-06

8.  The functionality and economic costs of outpatients with schizophrenia in Taiwan.

Authors:  I Hui Lee; Po See Chen; Yen Kuang Yang; Yi Cheng Liao; Yih Dar Lee; Tzung Lieh Yeh; Ling Ling Yeh; Shu Hui Cheng; Ching Lin Chu
Journal:  Psychiatry Res       Date:  2008-02-19       Impact factor: 3.222

9.  Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.

Authors:  Stacie B Dusetzina; Joel F Farley; Morris Weinberger; Bradley N Gaynes; Betsy Sleath; Richard A Hansen
Journal:  Psychiatr Serv       Date:  2012-10       Impact factor: 3.084

10.  Financial burden of health care expenditures: Turkey.

Authors:  S Nur Sulku; D Minbay Bernard
Journal:  Iran J Public Health       Date:  2012-03-31       Impact factor: 1.429

View more
  4 in total

1.  The Comparison of Various Types of Health Insurance in the Healthcare Utilization, Costs and Catastrophic Health Expenditures among Middle-Aged and Older Chinese Adults.

Authors:  Sha Chen; Zhiye Lin; Xiaoru Fan; Jushuang Li; Yao-Jie Xie; Chun Hao
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

Review 2.  Anti-TNF-α Compounds as a Treatment for Depression.

Authors:  Sarit Uzzan; Abed N Azab
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

3.  The quality of mental health care delivered to patients with schizophrenia and related disorders in the Italian mental health system. The QUADIM project: a multi-regional Italian investigation based on healthcare utilisation databases.

Authors:  Antonio Lora; Matteo Monzio Compagnoni; Liliana Allevi; Angelo Barbato; Flavia Carle; Barbara D'avanzo; Teresa Di Fiandra; Lucia Ferrara; Andrea Gaddini; Melania Leogrande; Alessio Saponaro; Salvatore Scondotto; Valeria D Tozzi; Simona Carbone; Giovanni Corrao
Journal:  Epidemiol Psychiatr Sci       Date:  2022-02-14       Impact factor: 6.892

4.  Does the mental health system provide effective coverage to people with schizophrenic disorder? A self-controlled case series study in Italy.

Authors:  Antonio Lora; Giovanni Corrao; Angelo Barbato; Barbara D'Avanzo; Teresa Di Fiandra; Lucia Ferrara; Andrea Gaddini; Matteo Monzio Compagnoni; Alessio Saponaro; Salvatore Scondotto; Valeria D Tozzi; Flavia Carle
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-06-16       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.